These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 415919)

  • 61. Sequential induction of nitric oxide synthase by Corynebacterium parvum in different organs of the mouse.
    Rees DD; Cunha FQ; Assreuy J; Herman AG; Moncada S
    Br J Pharmacol; 1995 Feb; 114(3):689-93. PubMed ID: 7537593
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of Corynebacterium parvum and cortisone on the primary Lewis tumour and its metastases.
    Jones PD; Sadler TE; Castro JE
    Int J Cancer; 1978 Jun; 21(6):784-8. PubMed ID: 669856
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Monocytes and macrophages in malignant melanoma IV. Effects of C. parvum on monocyte function.
    Hedley DW; Nyholm RE; Currie GA
    Br J Cancer; 1979 May; 39(5):558-65. PubMed ID: 486312
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The activation state of macrophage subpopulations from a murine fibrosarcoma.
    Moore K; McBride WH
    Int J Cancer; 1980 Nov; 26(5):609-15. PubMed ID: 6263810
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enhancement of hematopoietic response of mice by subcutaneous administration of Lactobacillus casei.
    Yokokura T; Nomoto K; Shimizu T; Nomoto K
    Infect Immun; 1986 Apr; 52(1):156-60. PubMed ID: 3082755
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Organ distributions and clearance studies of 99mtechnetium-labeled Corynebacterium parvum in patients with leukemia.
    Toki H; Hersh EM; Gutterman JU; Haynie TP; Glenn H; White RA; Rios A
    Int J Immunopharmacol; 1981; 3(2):141-5. PubMed ID: 7263121
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Macrophage precursors as cytotoxic effector cells (author's transl)].
    Lohmann-Matthes ML; Zähringer M
    Blut; 1981 May; 42(5):283-95. PubMed ID: 7236895
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Chemoattractant properties of Corynebacterium parvum and pyran copolymer for human monocytes and neutrophils.
    Majeski JA; Stinnett JD
    J Natl Cancer Inst; 1977 Mar; 58(3):781-3. PubMed ID: 839571
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of intracerebrally injected Corynebacterium parvum on implanted brain tumor in mice.
    Kennedy JD; Conley FK
    J Neurooncol; 1989 May; 7(1):89-101. PubMed ID: 2502606
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Subcutaneous Corynebacterium parvum in bladder cancer: a controlled study of its immunological effects.
    Purves EC; Snell M; Cope WA; Addison IE; Copland RF; Berenbaum MC
    Br J Urol; 1979 Aug; 51(4):278-82. PubMed ID: 380732
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Effect of Corynebacterium parvum on serum lysozyme (muramidase) levels (author's transl)].
    Eliopoulos G; Andre S; Anagnou NP; Meletis J; Halpern B
    Experientia; 1979 Jul; 35(7):908-9. PubMed ID: 477851
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intravascular coagulation resulting from intravenous injection of C. parvum in mice.
    Lampert IA; Jones PD; Sadler TE; Castro JE
    Br J Cancer; 1977 Jul; 36(1):15-22. PubMed ID: 889682
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Level of redox potential as a possible contributing influence in the pathogenicity of oral anaerobes.
    Jayawardene A; Goldner M
    Antonie Van Leeuwenhoek; 1975; 41(4):553-68. PubMed ID: 816253
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of intravenous corynebacterium parvum on peripheral-blood effector cells of cancer patients.
    Gill PG; Waller CA; MacClennan IC; Morris PJ
    Br J Cancer; 1980 May; 41(5):782-9. PubMed ID: 7426303
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunochemotherapy of breast cancer with Propionibacterium granulosum.
    Roszkowski K; Nozdryn-Plotnicki B; Roszkowski W; Ko HL; Pulverer G; Jeljaszewicz J
    Cancer Immunol Immunother; 1983; 15(1):23-6. PubMed ID: 6553504
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Small-cell lung cancer and immunochemotherapy with Propionibacterium granulosum KP 45.
    Roszkowski K; Nozdryn-Plotnicki B; Roszkowski W; Ko HL; Jeljaszewicz J; Pulverer G
    J Cancer Res Clin Oncol; 1985; 109(1):72-7. PubMed ID: 2982882
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effect of Corynebacterium parvum on the proliferation of monocyte precursors in the bone marrow of mice.
    Chare MJ; Baum M
    Dev Biol Stand; 1977 Apr 13-15; 38():195-200. PubMed ID: 415919
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of Corynebacterium parvum on colony-stimulating factor and granulocyte-macrophage colony formation.
    Foster RS; MacPherson BR; Browdie DA
    Cancer Res; 1977 May; 37(5):1349-55. PubMed ID: 300651
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of Corynebacterium parvum on the proliferative rate of granulocyte-macrophage progenitor cells and the toxicity of chemotherapy.
    Foster RS
    Cancer Res; 1978 Sep; 38(9):2666-72. PubMed ID: 679169
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of bone marrow depletion on prostaglandin E-producing suppressor macrophages in mouse spleen.
    Shibata Y; Volkman A
    J Immunol; 1985 Dec; 135(6):3897-904. PubMed ID: 2933455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.